000173061 001__ 173061
000173061 005__ 20210129214546.0
000173061 037__ $$aFZJ-2014-06474
000173061 041__ $$aEnglish
000173061 1001_ $$0P:(DE-Juel1)133369$$aFroning, Martina$$b0$$eCorresponding Author$$ufzj
000173061 1112_ $$aVI International Conference 'Semipalatinsk Test Site: Radiation Legacy and Development Perspectives'$$cKurchatow$$d2014-09-24 - 2014-09-26$$wKazakhstan
000173061 245__ $$aInternal Dosimetry after Inhalation of UF6 -  A Case Study
000173061 260__ $$c2014
000173061 3367_ $$0PUB:(DE-HGF)24$$2PUB:(DE-HGF)$$aPoster$$bposter$$mposter$$s1417689945_21917$$xAfter Call
000173061 3367_ $$033$$2EndNote$$aConference Paper
000173061 3367_ $$2DataCite$$aOutput Types/Conference Poster
000173061 3367_ $$2DRIVER$$aconferenceObject
000173061 3367_ $$2ORCID$$aCONFERENCE_POSTER
000173061 3367_ $$2BibTeX$$aINPROCEEDINGS
000173061 520__ $$aINTERNAL DOSIMETRY AFTER INHALATION OF UF6 - A CASE STUDYM. Froning, P. HillForschungszentrum Jülich GmbH, S-BI, 52425 Jülich, GermanyIntroduction: During a release of UF6 in a nuclear installation in Germany an employee was contaminated externally and internally. Inhaled uranium is in the chemical form UF6 very well soluble (class F) and can be easily taken up into blood and the lymphatic system.Monitoring: Extensive incorporation monitoring of urine and feces, as well as measurements of blood, nose-blow- and sputum samples on 234U, 235U and 238U followed immediately after the incident. The total monitoring period covered about 4 weeks.To enhance the excretion rate a solution of 8.4 percent sodium bicarbonate was administrated in the first few days as a means of medical precaution. During this time  urine and feces samples taken were essentially of low volume (e.g. spot samples). Excretion rates have been analyzed by means of ICP-MS and α-spectrometry. The latter was used for quality assurance of the results. The laboratory is flexibly accredited (DIN ISO/IEC 17025:2005) for these test methods.Dose assessment: Internal dose has been assessed following the rules of the official German guideline on incorporation monitoring. This guideline must be used for legal purposes.  An effective Dose of E = 0.8 mSv and a lung dose of HLung = 14.5 mSv have been calculated. Additionally expert software has been used for internal dose calculation. Since excretion rates in the beginning of the monitoring period were enhanced, later samples were especially helpful in realistically determing internal dose.Final remarks: The biocinetic uranium model of ICRP78[1] seems not to be adequate to describe excretion within the first hours after intake. The data obtained from spot samples during the first day  indicate  an underestimation of exretion rates by several orders of magnitude. The study shows that extended follow-up monitoring can help to clarify the dose relevant medium-term systemic uptake after an incident.A recent communication of the case study in English (extended abstract) can be found in ref. [2].[1] 	ICRP Publication 78; Individual Monitoring for Internal Exposure of Workers; Annals of the ICRP Vol. 27 No. 3/4, 1997[2]	M.Froning, H.Doerffel and P.Hill; Internal Dosimetry after Inhalation of UF6 - A Case Study; Fourth European IRPA Congress ‘Radiation Protection Culture – A global challenge, June 23-27,2014, Geneva, Switzerland; Book of abstracts, Paper PS5-04/6; http://www.irpa2014europe.com/downloads (last accessed: July, 28th 2014)
000173061 536__ $$0G:(DE-HGF)POF2-899$$a899 - ohne Topic (POF2-899)$$cPOF2-899$$fPOF I$$x0
000173061 7001_ $$0P:(DE-Juel1)133370$$aHill, Peter$$b1$$ufzj
000173061 773__ $$y2014
000173061 909CO $$ooai:juser.fz-juelich.de:173061$$pVDB
000173061 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133369$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000173061 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133370$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000173061 9132_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$aDE-HGF$$bForschungsbereich Materie$$lForschungsbereich Materie$$vohne Topic$$x0
000173061 9131_ $$0G:(DE-HGF)POF2-899$$1G:(DE-HGF)POF2-890$$2G:(DE-HGF)POF2-800$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000173061 9141_ $$y2014
000173061 920__ $$lyes
000173061 9201_ $$0I:(DE-Juel1)S-BI-20100518$$kS-BI$$lS-BI$$x0
000173061 9201_ $$0I:(DE-Juel1)S-B-20090406$$kS-B$$lBetrieblicher Strahlenschutz$$x1
000173061 980__ $$aposter
000173061 980__ $$aVDB
000173061 980__ $$aI:(DE-Juel1)S-BI-20100518
000173061 980__ $$aI:(DE-Juel1)S-B-20090406
000173061 980__ $$aUNRESTRICTED
000173061 981__ $$aI:(DE-Juel1)S-B-20090406